Advanced Ret Altered Malignancies clinical trials

Explore recruiting advanced ret altered malignancies clinical trials.

Recruiting advanced ret altered malignancies studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Ret Altered Malignancies trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Modular, Open-label, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of EP0031 in Patients with Advanced RET-altered Malignancies

Spain, France, Germany, Italy, Poland

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Ret Altered Malignancies trials by city

Advanced Ret Altered Malignancies in Toronto Advanced Ret Altered Malignancies in Vancouver Advanced Ret Altered Malignancies in Montreal Advanced Ret Altered Malignancies in Calgary Advanced Ret Altered Malignancies in Edmonton Advanced Ret Altered Malignancies in Ottawa Advanced Ret Altered Malignancies in Winnipeg Advanced Ret Altered Malignancies in Quebec City Advanced Ret Altered Malignancies in Hamilton Advanced Ret Altered Malignancies in Kitchener Advanced Ret Altered Malignancies in London Advanced Ret Altered Malignancies in Halifax Advanced Ret Altered Malignancies in New York Advanced Ret Altered Malignancies in Los Angeles Advanced Ret Altered Malignancies in Chicago Advanced Ret Altered Malignancies in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease